Longitudinal cohort study evaluates eptinezumab effectiveness in chronic migraine, indicating promising results for therapy initiation.
To evaluate the long-term real-world effectiveness of eptinezumab through a four-year longitudinal analysis of subjects initiating therapy.
No takes yet. Share an insight, caveat, or question.
Hsieh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: